Skip to main content

PHIBRO ANIMAL HEALTH CORP

For the period ended Mar 31, 2024. Filed May 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 8, 2024

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Changes in Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Other · ​ · ​ · ​
​ · ​ · Shares of · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Comprehensive · ​ · ​ · ​
​ · ​ · Common · ​ · Common · ​ · Preferred · ​ · Paid-in · ​ · Retained · ​ · Income · ​ · ​ · ​
​ · Stock · Stock · Stock · Capital · Earnings · (Loss) · Total
​ · ​ · (unaudited)
​ · ​ · (in thousands, except share and per share amounts)
As of June 30, 202340,503,608​$4​$—​$135,803​$260,912​$(114,210)​$282,509
Comprehensive income (loss)​—​​—​​—​​—​​(8,015)​​3,354​​(4,661)
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,860)​​—​​(4,860)
Stock-based compensation expense—​—​—​81​—​—​81
As of September 30, 2023​40,503,608​$4​$—​$135,884​$248,037​$(110,856)​$273,069
Comprehensive income​—​​—​​—​​—​​1,274​​1,241​​2,515
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,861)​​—​​(4,861)
Stock-based compensation expense​—​​—​​—​​80​​—​​—​​80
As of December 31, 202340,503,608​$4​$—​$135,964​$244,450​$(109,615)​$270,803
Comprehensive income (loss)​—​​—​​—​​—​​8,405​​(4,389)​​4,016
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,860)​​—​​(4,860)
Stock-based compensation expense​—​—​—​​135​​—​——​​135
As of March 31, 2024​40,503,608​$4​$—​$136,099​$247,995​$(114,004)​$270,094
​​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Other · ​ · ​ · ​
​ · ​ · Shares of · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Comprehensive · ​ · ​ · ​
​ · ​ · Common · ​ · Common · ​ · Preferred · ​ · Paid-in · ​ · Retained · ​ · Income · ​ · ​ · ​
​ · Stock · Stock · Stock · Capital · Earnings · (Loss) · Total
​ · ​ · (unaudited)
​ · ​ · (in thousands, except share and per share amounts)
As of June 30, 2022​40,503,608​$4​$—​$135,803​$247,748​$(121,113)​$262,442
Comprehensive income—​—​—​—​3,856​1,318​5,174
Dividends declared ($0.12 per share)—​—​—​—​(4,860)​—​(4,860)
As of September 30, 2022​40,503,608​$4​$—​$135,803​$246,744​$(119,795)​$262,756
Comprehensive income​—​​—​​—​​—​​7,210​​3,264​​10,474
Dividends declared ($0.12 per share)​—​​—​​—​​​​​(4,860)​​—​​(4,860)
As of December 31, 202240,503,608​$4​$—​$135,803​$249,094​$(116,531)​$268,370
Comprehensive income (loss)​—​​—​​—​​—​​10,042​​(1,223)​​8,819
Dividends declared ($0.12 per share)​—​​—​​—​​—​​(4,861)​​—​​(4,861)
As of March 31, 2023​40,503,608​$4​$—​$135,803​$254,275​$(117,754)​$272,328

The accompanying notes are an integral part of these consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.